HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LEADS BIOLABS-B

62.450

-1.700-2.65%

Volume:1.60M

Turnover:104.71M

Market Cap:12.43B

PE:-44.53

High:68.000

Open:64.500

Low:62.050

Close:64.150

52wk High:97.500

52wk Low:44.720

Shares:199.00M

HK Float Shares:198.00M

Volume Ratio:1.38

T/O Rate:0.81%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.402

ROE:-27.61%

ROA:-9.92%

PB:8.47

PE(LYR):-44.53

PS:60.50

Loading ...

Overview Company News Filings

New Forecasts: Here's What Analysts Think The Future Holds For Nanjing Leads Biolabs Co., Ltd. (HKG:9887)

Simply Wall St.

LEADS BIOLABS-B Shares Surge Over 11%, Marking a 30% Gain in Three Days on ESMO Research News

LEADS BIOLABS-B Shares Surge Over 15% as Key Drug Candidate LBL-024 Enters Priority Review

Leads Biolabs Says Six Studies Accepted for Presentation at ESMO 2026

Leads Biolabs Highlights R&D Momentum with Six Abstracts Accepted by 2026 ESMO, Including Two Top-Tier Oral Presentations

Bulletin Express

LEADS BIOLABS-B Announces Multiple Research Presentations Selected for Prestigious 2026 ESMO Congress

Nanjing Leads Biolabs Says Six Clinical Studies Win Presentation Slots at 2026 ESMO Meeting

LEADS BIOLABS-B Surges Over 27% in Morning Session as Velixicon® Application Granted Priority Review

Nanjing Leads Biolabs Co - Opamtistomig Bla for Advanced Ep-nec Granted Priority Review by China's Nmpa

THOMSON REUTERS

Nanjing Leads Biolabs Co Ltd: Actively Advancing Relevant Pre-launch Commercialization Preparations

THOMSON REUTERS

Priority Review Granted to Pd-l1/4-1bb Bispecific Antibody Opamtistomig, Accelerating Commercialization and Addressing Unmet Need in Ep-nec

THOMSON REUTERS

Nanjing Leads Biolabs' Cancer Drug Included in China Regulator's Priority Review List

MT Newswires Live

LEADS BIOLABS-B's Novel Cancer Therapy LBL-024 Granted Priority Review in China for Advanced Neuroendocrine Carcinoma

Nanjing Leads Biolabs Says China Regulator Puts Lbl-024 Ep-nec Filing in Priority Review

Leads Biolabs Converts 44.39 Million Unlisted Shares to H Shares, Lifting Outstanding H Shares to 197.67 Million

Bulletin Express

LEADS BIOLABS-B Awards 2.2547 Million Shares Under H-Share Incentive Scheme

Nanjing Leads Biolabs Grants 2,254,691 H-share Awards Under Employee Incentive Scheme

This Nanjing Leads Biolabs Insider Reduced Their Stake By 40%

Simply Wall St.

Assessing LEADS BIOLABS-B After a 50% Price Drop: H-Share Full Circulation, Early Shareholder Unlock, and Custody Movements

New Energy System Blueprint and Rural EV Initiative Unveiled as Key Stocks Report Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/09887/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09887","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","market":"HK","secType":"STK","nameCN":"LEADS BIOLABS-B","latestPrice":62.45,"timestamp":1784880485009,"preClose":64.15,"halted":0,"volume":1603642,"delay":0,"changeRate":-0.026500389711613448,"floatShares":198000000,"shares":199000000,"eps":-1.4023345958704843,"marketStatus":"Not Yet Opened","change":-1.7,"latestTime":"07-24 16:08:05","open":64.5,"high":68,"low":62.05,"amount":104710998,"amplitude":0.092751,"askPrice":62.45,"askSize":500,"bidPrice":62.4,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.3640891068921983,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1785115800000},"marketStatusCode":0,"adr":0,"listingDate":1753372800000,"exchange":"SEHK","adjPreClose":64.15,"openAndCloseTimeList":[[1784856600000,1784865600000],[1784869200000,1784880000000]],"volumeRatio":1.3815153334073509,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","floatShares":198000000,"roa":"-9.92%","roe":"-27.61%","lyrEps":-1.402335,"volumeRatio":1.3815153334073509,"shares":199000000,"dividePrice":0,"high":68,"amplitude":0.092751,"preClose":64.15,"low":62.05,"week52Low":44.72,"pbRate":"8.47","psRate":"60.50","week52High":97.5,"institutionHeld":0,"latestPrice":62.45,"eps":-1.4023345958704843,"divideRate":0,"volume":1603642,"delay":0,"ttmEps":-1.3640891068921983,"open":64.5,"prevYearClose":51,"prevWeekClose":62.45,"prevMonthClose":49.32,"prevQuarterClose":49.32,"fiveDayClose":64.5,"twentyDayClose":49.1,"sixtyDayClose":85.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09887\",params:#limit:5,,,undefined,":[{"date":"2026-03-27","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null},{"date":"2025-08-29","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09887\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09887\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1780070400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09887\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09887","date":"2026-07-24","current":-45.803176,"percent":0.258197,"low":-76.458084,"twenty":-44.356568,"median":-39.788614,"eighty":-34.393423,"high":-30.202688,"avg":-41.824579,"sd":10.124459,"marketCap":12420792910},"quantilePoints":[{"date":"2025-07-25","current":-39.760016,"twenty":-39.760016,"median":-39.760016,"eighty":-39.760016,"marketCap":12652000240},{"date":"2025-08-01","current":-42.800562,"twenty":-46.836196,"median":-44.399434,"eighty":-42.800562,"marketCap":13535375000},{"date":"2025-08-08","current":-41.931377,"twenty":-45.734702,"median":-43.894587,"eighty":-42.800562,"marketCap":13293671875},{"date":"2025-08-15","current":-42.360797,"twenty":-44.683717,"median":-42.975881,"eighty":-41.70245,"marketCap":13409689375},{"date":"2025-08-22","current":-41.268557,"twenty":-45.0887,"median":-43.050098,"eighty":-41.70245,"marketCap":13022964375},{"date":"2025-08-29","current":-41.462871,"twenty":-44.683717,"median":-42.745269,"eighty":-41.268557,"marketCap":13146747980},{"date":"2025-09-05","current":-41.718992,"twenty":-44.115151,"median":-41.93996,"eighty":-40.603026,"marketCap":13087080440},{"date":"2025-09-12","current":-41.612383,"twenty":-43.894587,"median":-41.766832,"eighty":-40.253447,"marketCap":13077135850},{"date":"2025-09-19","current":-40.406926,"twenty":-43.894587,"median":-41.814673,"eighty":-40.270938,"marketCap":12689296840},{"date":"2025-09-26","current":-39.940552,"twenty":-43.592616,"median":-41.710721,"eighty":-39.940552,"marketCap":12510294220},{"date":"2025-10-03","current":-46.021818,"twenty":-44.124681,"median":-41.829747,"eighty":-40.190868,"marketCap":14449489270},{"date":"2025-10-10","current":-44.344385,"twenty":-44.480118,"median":-41.935668,"eighty":-40.263942,"marketCap":13902536820},{"date":"2025-10-17","current":-41.267963,"twenty":-44.480118,"median":-42.061577,"eighty":-40.352531,"marketCap":12927967000},{"date":"2025-10-24","current":-37.571928,"twenty":-44.331016,"median":-41.888099,"eighty":-40.263942,"marketCap":11774394560},{"date":"2025-10-31","current":-34.030535,"twenty":-44.258383,"median":-41.766832,"eighty":-39.846145,"marketCap":10680489660},{"date":"2025-11-07","current":-37.063837,"twenty":-44.143742,"median":-41.612383,"eighty":-39.421071,"marketCap":11625225710},{"date":"2025-11-14","current":-37.306884,"twenty":-44.026925,"median":-41.504614,"eighty":-38.171485,"marketCap":11734616200},{"date":"2025-11-21","current":-32.263354,"twenty":-43.773799,"median":-41.293984,"eighty":-37.626872,"marketCap":10143481800},{"date":"2025-11-28","current":-33.407237,"twenty":-43.416049,"median":-41.25873,"eighty":-37.278832,"marketCap":10541265400},{"date":"2025-12-05","current":-32.531883,"twenty":-43.110759,"median":-40.854935,"eighty":-36.232015,"marketCap":10282706060},{"date":"2025-12-12","current":-33.445348,"twenty":-43.033782,"median":-40.504976,"eighty":-34.804627,"marketCap":10590988350},{"date":"2025-12-19","current":-31.455565,"twenty":-42.962519,"median":-40.253447,"eighty":-33.697999,"marketCap":9984368360},{"date":"2025-12-24","current":-31.920084,"twenty":-42.892338,"median":-39.907071,"eighty":-33.445348,"marketCap":10163370980},{"date":"2026-01-02","current":-31.421623,"twenty":-42.818917,"median":-39.811672,"eighty":-33.24713,"marketCap":10044035900},{"date":"2026-01-09","current":-34.757237,"twenty":-42.712093,"median":-39.628079,"eighty":-33.303022,"marketCap":11137940800},{"date":"2026-01-16","current":-34.953981,"twenty":-42.570843,"median":-39.220132,"eighty":-33.387129,"marketCap":11237386700},{"date":"2026-01-23","current":-34.708884,"twenty":-42.534258,"median":-38.04671,"eighty":-33.234922,"marketCap":11147885390},{"date":"2026-01-30","current":-41.208386,"twenty":-42.402729,"median":-37.93488,"eighty":-33.285275,"marketCap":13295916830},{"date":"2026-02-06","current":-38.552413,"twenty":-42.362692,"median":-38.04671,"eighty":-33.303022,"marketCap":12470515860},{"date":"2026-02-13","current":-37.506904,"twenty":-42.335079,"median":-38.011119,"eighty":-33.387129,"marketCap":12202011930},{"date":"2026-02-20","current":-39.795685,"twenty":-42.275235,"median":-38.202679,"eighty":-33.413439,"marketCap":12927967000},{"date":"2026-02-27","current":-37.9711,"twenty":-42.061223,"median":-38.358648,"eighty":-33.438876,"marketCap":12470515860},{"date":"2026-03-06","current":-32.876582,"twenty":-42.035836,"median":-37.973315,"eighty":-33.326804,"marketCap":10710323430},{"date":"2026-03-13","current":-37.800338,"twenty":-41.938243,"median":-37.9711,"eighty":-33.411645,"marketCap":12371069960},{"date":"2026-03-20","current":-39.652105,"twenty":-41.914066,"median":-38.162788,"eighty":-33.431073,"marketCap":12927967000},{"date":"2026-03-27","current":-45.563334,"twenty":-41.938243,"median":-38.422097,"eighty":-33.438876,"marketCap":14817439100},{"date":"2026-04-02","current":-73.055706,"twenty":-42.061577,"median":-38.676054,"eighty":-33.441386,"marketCap":17572695150},{"date":"2026-04-10","current":-74.98239,"twenty":-42.364587,"median":-38.815397,"eighty":-33.443763,"marketCap":18175244000},{"date":"2026-04-17","current":-69.940613,"twenty":-42.73421,"median":-39.081216,"eighty":-33.482556,"marketCap":16960268450},{"date":"2026-04-24","current":-67.940785,"twenty":-43.090538,"median":-39.261059,"eighty":-33.558052,"marketCap":16476253800},{"date":"2026-04-30","current":-65.13036,"twenty":-44.026925,"median":-39.582143,"eighty":-33.605745,"marketCap":15804560000},{"date":"2026-05-08","current":-55.847576,"twenty":-44.547984,"median":-39.760016,"eighty":-33.640661,"marketCap":16030679080},{"date":"2026-05-15","current":-43.849045,"twenty":-45.37348,"median":-39.795589,"eighty":-33.697999,"marketCap":12619684710},{"date":"2026-05-22","current":-44.434352,"twenty":-44.931837,"median":-39.87359,"eighty":-33.778461,"marketCap":12758908970},{"date":"2026-05-29","current":-42.313126,"twenty":-44.693978,"median":-39.965338,"eighty":-33.850015,"marketCap":12192067340},{"date":"2026-06-05","current":-38.943344,"twenty":-44.633844,"median":-39.952945,"eighty":-33.989804,"marketCap":11237386700},{"date":"2026-06-12","current":-37.176407,"twenty":-44.416359,"median":-39.831455,"eighty":-34.116239,"marketCap":10720268020},{"date":"2026-06-18","current":-37.166904,"twenty":-44.344385,"median":-39.795685,"eighty":-34.459057,"marketCap":10740157200},{"date":"2026-06-26","current":-34.282345,"twenty":-44.322103,"median":-39.774315,"eighty":-34.282345,"marketCap":9861055444},{"date":"2026-07-03","current":-36.446991,"twenty":-44.194662,"median":-39.640092,"eighty":-34.070689,"marketCap":10491542450},{"date":"2026-07-10","current":-34.534018,"twenty":-44.124681,"median":-39.536207,"eighty":-34.070689,"marketCap":9928678656},{"date":"2026-07-17","current":-44.462046,"twenty":-44.326559,"median":-39.640092,"eighty":-34.242022,"marketCap":12828521100},{"date":"2026-07-24","current":-43.03924,"twenty":-44.356568,"median":-39.788614,"eighty":-34.393423,"marketCap":12420792910}],"updateTime":1785101419602},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09887\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653718166","title":"New Forecasts: Here's What Analysts Think The Future Holds For Nanjing Leads Biolabs Co., Ltd. (HKG:9887)","url":"https://stock-news.laohu8.com/highlight/detail?id=2653718166","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653718166?lang=en_us&edition=fundamental","pubTime":"2026-07-23 07:20","pubTimestamp":1784762457,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs Co., Ltd. ( HKG:9887 ) shareholders will have a reason to smile today, with the analysts making...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9887/nanjing-leads-biolabs-shares/news/new-forecasts-heres-what-analysts-think-the-future-holds-for-321","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9887/nanjing-leads-biolabs-shares/news/new-forecasts-heres-what-analysts-think-the-future-holds-for-321","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09887","BK1161","HK0000252160.HKD","HK0000500386.USD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175511625","title":"LEADS BIOLABS-B Shares Surge Over 11%, Marking a 30% Gain in Three Days on ESMO Research News","url":"https://stock-news.laohu8.com/highlight/detail?id=1175511625","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175511625?lang=en_us&edition=fundamental","pubTime":"2026-07-15 14:32","pubTimestamp":1784097144,"startTime":"0","endTime":"0","summary":"Shares of LEADS BIOLABS-B (09887) have surged by over 11% today, extending a rally that has seen the stock gain more than 30% over the past three trading sessions.As of the latest update, the stock...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","HK0000500386.USD","KCAI","09887","VXUS","BK4585","HK0000252160.HKD","BK4588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156225075","title":"LEADS BIOLABS-B Shares Surge Over 15% as Key Drug Candidate LBL-024 Enters Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1156225075","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156225075?lang=en_us&edition=fundamental","pubTime":"2026-07-14 11:52","pubTimestamp":1784001137,"startTime":"0","endTime":"0","summary":"Shares of LEADS BIOLABS-B (09887) surged more than 15% during the morning trading session.As of the latest update, the stock is up 6.39%, trading at HK$63.30 with a turnover of HK$167 million.The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","HK0000252152.HKD","BK1161","HK0000500386.USD","09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651192431","title":"Leads Biolabs Says Six Studies Accepted for Presentation at ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651192431","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651192431?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:58","pubTimestamp":1783933130,"startTime":"0","endTime":"0","summary":"Leads Biolabs says six studies accepted for presentation at ESMO 2026Nanjing Leads Biolabs flagged a potential catalyst as it secured Late-Breaking Abstract status for ESMO 2026, with the full submiss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL2gtKVv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","BK1161","HK0000500386.USD","HK0000252152.HKD","09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140815382","title":"Leads Biolabs Highlights R&D Momentum with Six Abstracts Accepted by 2026 ESMO, Including Two Top-Tier Oral Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=1140815382","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140815382?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:43","pubTimestamp":1783932228,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs”, HK: 09887) reported that six of its latest oncology studies have been selected for presentation at the 2026 annual meeting of the European Society...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132253753","title":"LEADS BIOLABS-B Announces Multiple Research Presentations Selected for Prestigious 2026 ESMO Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=1132253753","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132253753?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:40","pubTimestamp":1783932034,"startTime":"0","endTime":"0","summary":"The biopharmaceutical company LEADS BIOLABS-B (ASX: 09887) has announced that six of its latest research findings have been accepted for presentation at the 2026 European Society for Medical Oncology...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887","HK0000252160.HKD","HK0000252152.HKD","BK1161","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651194299","title":"Nanjing Leads Biolabs Says Six Clinical Studies Win Presentation Slots at 2026 ESMO Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2651194299","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651194299?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:37","pubTimestamp":1783931830,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs says six clinical studies win presentation slots at 2026 ESMO meetingNanjing Leads Biolabs outlined six studies accepted for presentation at the 2026 ESMO meeting in Madrid on Oc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL6cGTfx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000252152.HKD","09887","HK0000500386.USD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143216016","title":"LEADS BIOLABS-B Surges Over 27% in Morning Session as Velixicon® Application Granted Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1143216016","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143216016?lang=en_us&edition=fundamental","pubTime":"2026-07-13 11:31","pubTimestamp":1783913508,"startTime":"0","endTime":"0","summary":"Shares of LEADS BIOLABS-B (09887) surged more than 27% in the morning trading session. At the time of writing, the stock was up 27.40%, trading at HK$63.60 with a turnover of HK$202 million. On July...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","HK0000252160.HKD","HK0000500386.USD","BK1161","09887","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650619185","title":"Nanjing Leads Biolabs Co - Opamtistomig Bla for Advanced Ep-nec Granted Priority Review by China's Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2650619185","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650619185?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:55","pubTimestamp":1783673703,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43C013:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000252152.HKD","HK0000500386.USD","09887","HK0000252160.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650318595","title":"Nanjing Leads Biolabs Co Ltd: Actively Advancing Relevant Pre-launch Commercialization Preparations","url":"https://stock-news.laohu8.com/highlight/detail?id=2650318595","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650318595?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:55","pubTimestamp":1783673703,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43C013:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000500386.USD","09887","BK1161","HK0000252160.HKD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650185616","title":"Priority Review Granted to Pd-l1/4-1bb Bispecific Antibody Opamtistomig, Accelerating Commercialization and Addressing Unmet Need in Ep-nec","url":"https://stock-news.laohu8.com/highlight/detail?id=2650185616","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650185616?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:55","pubTimestamp":1783673703,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43C013:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000500386.USD","BK1161","09887","HK0000252152.HKD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650907770","title":"Nanjing Leads Biolabs' Cancer Drug Included in China Regulator's Priority Review List","url":"https://stock-news.laohu8.com/highlight/detail?id=2650907770","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650907770?lang=en_us&edition=fundamental","pubTime":"2026-07-10 15:08","pubTimestamp":1783667303,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs'  biologics license application for LBL-024 was approved for inclusion in priority review and approval procedure by China's National Medical Products Administration.The drug has been developed as monotherapy for the treatment of advanced extrapulmonary neuroendocrine carcinoma, according to a Friday Hong Kong bourse filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000252152.HKD","HK0000500386.USD","09887","HK0000252160.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114500368","title":"LEADS BIOLABS-B's Novel Cancer Therapy LBL-024 Granted Priority Review in China for Advanced Neuroendocrine Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1114500368","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114500368?lang=en_us&edition=fundamental","pubTime":"2026-07-10 12:34","pubTimestamp":1783658060,"startTime":"0","endTime":"0","summary":"The biologics license application for LEADS BIOLABS-B's (ASX: 09887) investigational drug, VELIXIN™ (the PD-L1/4-1BB bispecific antibody oplitelimab, LBL-024), as a monotherapy for advanced...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU1169589451.USD","09887","LU1169590202.USD","HK0000252152.HKD","HK0000252160.HKD","BK4023","HK0000500386.USD","PD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650901310","title":"Nanjing Leads Biolabs Says China Regulator Puts Lbl-024 Ep-nec Filing in Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2650901310","media":"Reuters","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650901310?lang=en_us&edition=fundamental","pubTime":"2026-07-10 12:28","pubTimestamp":1783657691,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs says China regulator puts LBL-024 EP-NEC filing in priority reviewNanjing Leads Biolabs’ China BLA for LBL-024 (opamtistomig) in advanced EP-NEC entered NMPA-CDE priority review.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDL8LMSg9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","BK1161","HK0000500386.USD","HK0000252160.HKD","09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189242408","title":"Leads Biolabs Converts 44.39 Million Unlisted Shares to H Shares, Lifting Outstanding H Shares to 197.67 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1189242408","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189242408?lang=en_us&edition=fundamental","pubTime":"2026-07-02 17:25","pubTimestamp":1782984351,"startTime":"0","endTime":"0","summary":"On 02 July 2026, Nanjing Leads Biolabs Co., Ltd. filed its Monthly Return for the period ended 30 June 2026 with Hong Kong Exchanges and Clearing Limited, detailing a sizeable realignment of its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183498438","title":"LEADS BIOLABS-B Awards 2.2547 Million Shares Under H-Share Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1183498438","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183498438?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:20","pubTimestamp":1782908424,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B (09887) has announced the granting of a total of 2.2547 million share awards under its H-share incentive scheme.The awards were granted to 149 recipients on July 1, 2026, and are subject to acceptance by the grantees to become effective.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","09887","BK1161","HK0000252152.HKD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648051015","title":"Nanjing Leads Biolabs Grants 2,254,691 H-share Awards Under Employee Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2648051015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648051015?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:45","pubTimestamp":1782906351,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs grants 2,254,691 H-share awards under employee incentive schemeNanjing Leads Biolabs granted 2,254,691 share Awards under its H Share Award Scheme, covering 149 employees.Executi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL8wPBMC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","HK0000252152.HKD","09887","BK1161","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647575581","title":"This Nanjing Leads Biolabs Insider Reduced Their Stake By 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647575581","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647575581?lang=en_us&edition=fundamental","pubTime":"2026-06-30 09:44","pubTimestamp":1782783864,"startTime":"0","endTime":"0","summary":"From what we can see, insiders were net sellers in Nanjing Leads Biolabs Co., Ltd.'s ( HKG:9887 ) during the past 12...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9887/nanjing-leads-biolabs-shares/news/this-nanjing-leads-biolabs-insider-reduced-their-stake-by-40","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9887/nanjing-leads-biolabs-shares/news/this-nanjing-leads-biolabs-insider-reduced-their-stake-by-40","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000500386.USD","HK0000252160.HKD","HK0000252152.HKD","09887","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119804571","title":"Assessing LEADS BIOLABS-B After a 50% Price Drop: H-Share Full Circulation, Early Shareholder Unlock, and Custody Movements","url":"https://stock-news.laohu8.com/highlight/detail?id=1119804571","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119804571?lang=en_us&edition=fundamental","pubTime":"2026-06-26 09:59","pubTimestamp":1782439157,"startTime":"0","endTime":"0","summary":"Since last September, the Hong Kong stock market's innovative drug sector has shifted from its previous bull market state, entering a volatile downtrend, with a particularly persistent decline...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","09887","HK0000252152.HKD","HK0000500386.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107543120","title":"New Energy System Blueprint and Rural EV Initiative Unveiled as Key Stocks Report Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1107543120","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107543120?lang=en_us&edition=fundamental","pubTime":"2026-06-26 07:26","pubTimestamp":1782429979,"startTime":"0","endTime":"0","summary":"Two major national plans have been announced, focusing on the development of a new energy system by 2030 and a new round of rural new energy vehicle promotion. Key Developments The National...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","80020","BK1613","BK1615","09879","BK1502","HK0000320223.HKD","HK0000252160.HKD","HK0000500386.USD","HK0000306685.HKD","03998","BK1161","BK1109","BK1227","BK1500","159945","HK0000165453.HKD","BK1574","09887","HK0000252152.HKD","BK1589","VXUS","02616","HK0000320264.USD","BK1113","LU1675838814.USD","02696","BK4585","LU1808992512.USD","BK4588","BK1512","00020"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":104,"code":"91000000","status":"200"}]}}